DEFINITION of hyperplasia

The term hyperplasia refers to an increase in the amount of organic tissue resulting from cellular proliferation. It frequently leads to the gross enlargement of an organ. Hyperplasia is generally a reversible, physiological, or pathological response to a specific stimulus (such as hormonal surges, chronic irritation, or compensatory demand). Crucially, the cells in hyperplasia remain normal in appearance and organization, distinguishing it from dysplasia (abnormal cell changes) and neoplasia (cancerous or benign tumors). Common clinical manifestations include Benign Prostatic Hyperplasia (BPH) and endometrial hyperplasia.


ETYMOLOGY of hyperplasia

greek

ComponentOriginMeaning
hyper-Greek hyper (ὑπέρ)Over”, “above”, or “excessive
-plasiaGreek -plasia (-πλασία), from plasseinFormation”, “growth”, or “molding

The roots combine directly to mean “excessive formation” or “overgrowth.” The term emerged in the mid-19th century as microscopic pathology evolved, allowing physicians to distinguish between tissue enlargement caused by larger cells (hypertrophy) versus more numerous cells (hyperplasia).


🔀 ALIASES / ALTERNATE TERMS

  • Cellular proliferation
  • Tissue overgrowth
  • Benign prostatic hyperplasia (BPH) (common clinical variant)
  • Endometrial hyperplasia
  • Congenital adrenal hyperplasia (CAH)
  • Gingival hyperplasia
  • Atypical hyperplasia (when the proliferating cells show slight abnormalities)

🔗 RELATED TERMS

  • Hypertrophy — an increase in the size of individual cells, rather than the number of cells (e.g., muscle hypertrophy).
  • dysplasia — abnormal development or alteration in the shape, size, and organization of cells; often a precancerous state.
  • Neoplasia — uncontrolled, autonomous new cellular growth (tumors), which can be benign or malignant.
  • Metaplasia — the reversible transformation of one differentiated mature cell type into another.
  • Hypoplasia — underdevelopment or incomplete tissue formation (the antonym of hyperplasia).
  • Atypia — structural abnormality in a cell; atypical hyperplasia carries a higher risk of progressing to cancer.

CODING CORNER


🏥 ICD-10-CM CODES

Prostatic Hyperplasia

CodeDescription
N40.0Benign prostatic hyperplasia without lower urinary tract symptoms
N40.1Benign prostatic hyperplasia with lower urinary tract symptoms
N40.2Nodular prostate without lower urinary tract symptoms
N40.3Nodular prostate with lower urinary tract symptoms

Endometrial Hyperplasia

CodeDescription
N85.00Endometrial hyperplasia, unspecified
N85.01Benign endometrial hyperplasia
N85.02Endometrial intraepithelial neoplasia [EIN]

Other Specified Hyperplasias

CodeDescription
K06.1Gingival enlargement (includes gingival hyperplasia)
E25.0Congenital adrenogenital disorders associated with enzyme deficiency (Congenital adrenal hyperplasia)
N60.31Fibrosclerosis of right breast (includes hyperplasia of breast)
N60.32Fibrosclerosis of left breast (includes hyperplasia of breast)

CPT CodeDescription
52601Transurethral electrosurgical resection of prostate, including control of postoperative bleeding, complete (vasectomy, meatotomy, cystourethroscopy, urethral calibration and/or dilation, and internal urethrotomy are included) (TURP for BPH)
53850Transurethral destruction of prostate tissue; by microwave thermotherapy (TUMT for BPH)
58100Endometrial sampling (biopsy) with or without endocervical sampling (biopsy), without cervical dilation, any method (separate procedure)
58558Hysteroscopy, surgical; with sampling (biopsy) of endometrium and/or polypectomy, with or without D & C
41820Gingivectomy, excision gingiva, each quadrant
88305Level IV - Surgical pathology, gross and microscopic examination (the standard path evaluation to confirm hyperplasia vs. neoplasia)

⚠️ Coding Note: Context is critical when coding hyperplasia, as it manifests differently depending on the organ system. For Benign Prostatic Hyperplasia (BPH), ICD-10 requires knowing if the patient has associated Lower Urinary Tract Symptoms (LUTS) to choose between N40.0 and N40.1. If N40.1 is used, an additional code must be assigned to identify the specific symptoms (e.g., incomplete bladder emptying, urinary frequency). For endometrial hyperplasia, coders must look closely at pathology reports to determine if it is benign (N85.01) or if there is atypia/EIN (N85.02), as the latter carries a significantly higher risk for malignancy and drives different clinical management.



Med roots Appendix A Prefixes Appendix B Combining Forms Appendix C Suffixes Appendix D Suffix forms